In summary, the preparation,characterization, and preliminary therapeutic study of the novel nanosystemsbased on the functionalization of MSNs with a cocktail of therapeuticmolecules, leptin and pioglitazone, has proven the high potentialof this nanoplatform for the treatment of ALS. This evidence concerns the gene LEP and amyotrophic lateral sclerosis.